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Background: Slow walking speed, time to perform the five-times-sit-to-stand (FTSS)
test and motoric cognitive risk syndrome (MCR; defined as slow gait speed combined
with subjective cognitive complaint) have been separately used to screen older
individuals at risk of cognitive decline. This study seeks to (1) compare the characteristics
of older individuals with MCR, as defined through slow walking speed and/or increased
FTSS time; and (2) examine the relationship between MCR and its motor components
as well as amnestic (a-MCI) and non-amnestic (na-MCI) Mild Cognitive Impairment.
Methods: A total of 633, individuals free of dementia, were selected from the cross-
sectional “Gait and Alzheimer Interactions Tracking” study. Slow gait speed and
increased FTSS time were used as criteria for the definition of MCR. Participants were
separated into five groups, according to MCR status: MCR as defined by (1) slow gait
speed exclusively (MCRs); (2) increased FTSS time exclusively (MCRf); (3) slow gait
speed and increased FTSS time (MCRsaf); (4) MCR; irrespective of the mobility test
used (MCRsof); and (5) the absence of MCR. Cognitive status (i.e., a-MCI, na-MCI,
cognitively healthy) was also determined.
Results: The prevalence of MCRs was higher, when compared to the prevalence
of MCRf (12.0% versus 6.2% with P ≤ 0.001). There existed infrequent overlap
(2.4%) between individuals exhibiting MCRs and MCRf, and frequent overlap between
individuals exhibiting MCRs and na-MCI (up to 50%). a-MCI and na-MCI were negatively
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[odd ratios (OR)≤ 0.17 with P≤ 0.019] and positively (OR≥ 2.41 with P≤ 0.019) related
to MCRs, respectively.
Conclusion: Individuals with MCRf are distinct from those with MCRs. MCRf status
does not relate to MCI status in the same way that MCRs does. MCRs is related
negatively to a-MCI and positively to na-MCI. These results suggest that FTTS cannot
be used to define MCR when the goal is to predict the risk of cognitive decline, such as
future dementia.
Keywords: older inpatients, epidemiology, screening, cognition, motricity
INTRODUCTION
Motoric cognitive risk syndrome (MCR) is defined as the
relationship between objective slow gait speed and subjective
cognitive complaint (Verghese et al., 2013). MCR is one of the
stages of pre-dementia, similar to mild cognitive impairment
(MCI) (Verghese et al., 2013, 2014). MCR does not require a
time-consuming comprehensive neuropsychological assessment
when compared to MCI, which opens new perspectives in terms
of detection of individuals who are at risk of dementia in older
populations (Verghese et al., 2013, 2014; Belleville et al., 2017).
The past decade has been characterized by an increased interest
in identifying and validating biomarkers for early diagnosis
and identification of individuals who are at risk of dementia
(Belleville et al., 2017). However, the use of biomarkers has
limitations in many settings. For instance, access to neuroimaging
is difficult and the cost of biological biomarkers limits their use
(Handels et al., 2017). Additionally, the highest prevalence and
incidence of dementia in the coming years will be observed in
low and intermediate income countries, where the accessibility
of actual biomarkers is limited (de Jager et al., 2017). Hence,
there is a need to optimize and increase the accessibility to
clinical risk assessment of dementia in community-dwelling older
populations. Using a motor test to predict dementia in older
populations may be a solution.
Motoric cognitive risk syndrome has the potential to rapidly
screen individuals who are at risk of dementia in a primary
care setting, where the under-diagnosis of dementia is estimated
to be around 50% in individuals over 65 (Iliffe et al., 2009).
This under-diagnosis of dementia is largely related to limited
resources and the time required for in-depth assessments of
cognitive complaint (Iliffe et al., 2009; Villars et al., 2010). The
simplicity of assessment of MCR syndrome could help overcome
this issue. However, gait speed, a component of MCR, may be
difficult to assess during a primary care visit because of space
constraints (Abellan van Kan et al., 2009). Gait speed must be
recorded at usual steady state pace rhythm over at least 3 meters
(Middleton et al., 2015). Few consultation rooms in primary care
possess the features required for the assessment of gait speed,
which complexifies the process of consultation and increases
physician workload and consult time, when gait speed must
be measured. It has been reported that consult time in general
practice is very short (around 6.9 min) and depends on the
physician, the physician’s workload and the type of visit (Petek
Ster et al., 2008). There is, therefore, a need in primary care
for a simpler mobility test, which can be completed rapidly and
within limited space, so as to facilitate MCR diagnosis in primary
settings. In addition, the chosen motor test must be proven to
show a link to cognitive impairment or risk of dementia, as the
objective of a redefined MCR is to identify individuals at risk of
dementia.
The five-times-sit-to-stand test (FTSS) is a physical test,
which measures the time taken by an individual to repeat
five consecutive chair rises as quickly as possible (Whitney
et al., 2005). This motor test examines the challenged balance
condition, which is the transfer from a sitting position to a
stand-up position. The FTSS test possesses the necessary features
for assessment of mobility performance to diagnose MCR in
primary care, as it can easily and rapidly be performed in
limited space and its requirements are limited to a chair and a
stopwatch. In addition, this test may be performed at the time
of consultation, as its duration is of fewer less than 2 min in
length, including explanation and performance (Whitney et al.,
2005). Thus, the FTSS test does not increase the physician’s
workload. The one-leg-balance (OLB) test is another simple
motor test to examine the challenged balance condition. In
it, the individual is asked to stand unassisted on one leg. An
impaired OLB test result – defined as being unable to stand on
one leg for 5 s – has been identified as a predictor of injurious
falls among community-dwelling older adults and cognitive
decline in patients with dementia, but not in non-demented
individuals (Vellas et al., 1997). In contrast, increased FTSS
time has been associated with low cognitive performance in
older community dwellers free of dementia (Annweiler et al.,
2011). Because non-demented individuals with poor cognitive
performance like MCI are at risk of dementia, this association
suggests that poor FTSS performance (i.e., increased time) may
be used to identify individuals at risk of dementia and thus,
that it could be used as an alternate motor test, as opposed to
gait speed, to define MCR. Using FTSS performance instead of
gait speed to define MCR value for the prediction of dementia
requires an investigation, which will determine whether or not
individuals classified as MCR through FTSS performance and
gait speed are one and the same. This line of questioning
is justified, as the FTSS test explores different subdomains of
mobility, when compared to gait speed (Whitney et al., 2005;
Annweiler et al., 2011; Beauchet et al., 2017; Sekhon et al.,
2017). The FTSS test examines the ability to transfer from a
sitting position and depends largely on balance control, muscle
mass, strength, and the power of lower limbs (Whitney et al.,
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2005). In comparison, gait speed is a surrogate measure of gait
ability, which depends on different body movements and higher
levels of movement control involving executive and memory
functions (Abellan van Kan et al., 2009; Middleton et al., 2015;
Beauchet et al., 2017). These differences between the FTSS
test and gait speed, therefore, call into question the possible
overlap between individuals whose MCR status was determined
using either the FTSS test or gait speed, and their relative
MCI.
Motoric cognitive risk syndrome and cognitive impairment
are both intermediate stages between normal cognitive aging
and major neurocognitive disorders (Verghese et al., 2013, 2014;
Belleville et al., 2017). A knowledge gap exists regarding the
relationship between MCR and MCI syndromes. Recently, we
underscored that there exists overlap between MCR – defined
through slow gait speed – and MCI in the population of older
community dwellers (Sekhon et al., 2017). The prevalence of
MCI was higher in individuals with MCR, when compared to
those without MCR (47.2% versus 39.5%) (Sekhon et al., 2017).
Unfortunately, the relationship between MCR subcategories of
MCI syndromes such as amnestic (a-MCI) and non-amnestic
(na-MCI) has not been examined in this study. As gait is
largely controlled by executive functions (Beauchet et al., 2017),
we have hypothesized that MCR as defined by slow gait
speed (MCRs) may be more frequently associated with na-
MCI, when compared to MCR as defined by increased FTSS
time (MCRf), which may be associated with a-MCI. Using
the data of the cross-sectional study known as the “Gait
and Alzheimer interactions tracking” (GAIT) study (Beauchet
et al., 2018), we had the opportunity to explore the overlap
between MCR as defined by slow gait speed and increased
FTSS time, and their relationship with a-MCI and na-MCI. This
study aims to (1) compare the characteristics of participants
of the GAIT study with and without MCR as defined by slow
gait speed and increased time of FTSS, and (2) examine the
relationship between MCR, and a-MCI and na-MCI. Comparing
gait speed and FTSS as a construct of MCR, as well as their
relationship with MCI subtypes, may provide new insight into
the interaction between motor and cognitive impairment in the
aging population.
MATERIALS AND METHODS
Population and Study Design
A subgroup of older individuals recruited in the GAIT study
were selected for the present study. The GAIT study is a cross-
sectional design-based study, which was conducted in France
between November 2009 and 2015 (Beauchet et al., 2018). All
GAIT participants were relatively healthy community-dwelling
individuals, who were recruited during a visit in the memory
clinic of Angers University Hospital, in France, for cognitive
complaint evaluation. The GAIT study inclusion criteria were:
(1) age 65 years and over, (2) living at home in the community,
and (3) an adequate understanding of French. Exclusion
criteria included acute medical illness (regardless of nature)
in the past month; extrapyramidal rigidity of the upper limbs
(regardless of etiology); neurological diseases [past history of
stroke, (NPH), multiple sclerosis, Parkinson’s disease, cerebellar
disease, polyneuropathy, and vestibular disease]; psychiatric
diseases (past history of psychosis, personality disorders or severe
depression as well as active depression as defined by a 4-item
geriatric depression scale (GDS) score above 1) (Shah et al.,
1997) other than cognitive impairment; severe gait-affecting
medical conditions which left potential participants with the
inability to walk unassisted for 15 min, such as rheumatologic
diseases (spine, pelvic, and joint arthritis with deformation); and
ophthalmic diseases with severe vision abnormality. In addition,
for the present study, we also excluded participants with NPH
or presenting vascular brain abnormalities (i.e., lacunar lesions
and strokes) on brain imaging [i.e., computed tomography (CT)
or magnetic resonance imagery (MRI) scan] performed during
the assessment, suffering from dementia, using a walking aid,
and presenting no gait speed or FTSS time data. A total of
663 participants were selected, after applying these selection
criteria.
Study Assessments
The selected GAIT participants had a full-standardized clinical
examination, a comprehensive neuropsychological assessment,
brain imaging (i.e., MRI or CT) and blood tests including Vitamin
B12, TSH, calcemia and other serum electrolytes, creatinine, and
urea. Age, sex, educational level [evaluated by number of years of
schooling and categorized by high school level (i.e., yes or no)],
number of drugs taken daily and body mass index (BMI; kg/m2)
were recorded. Maximal isometric voluntary contraction (MVC)
strength of hand was measured with the help of a computerized
hydraulic dynamometer (Martin Vigorimeter, Medizin Tecnik,
Tutlingen, Germany). The test was performed once on each
side. The highest MVC value recorded was used in the present
data analysis. Binocular distance vision was measured at 5 m
with a standard Monoyer letter chart and scored from 0 (i.e.,
worst performance) to 10 (i.e., best performance) (Lord et al.,
1991b). Vision was assessed with corrective lenses if needed.
Lower-limb proprioception was evaluated with the help of a
graduated tuning fork placed on the tibial tuberosity, so as to
measure vibration threshold (Buchman et al., 2009). The mean
value obtained for the left and right sides ranged between 0
(i.e., worst performance) and 8 (i.e., best performance) and was
used in the present data analysis. Gait speed was measured
with the help of GAITRite R© (Gold walkway, 972 cm long, active
electronic surface area 792 cm× 610 cm, total of 29,952 pressure
sensors, scanning frequency 60 Hz, CIR System, Havertown,
PA, United States). Time to perform FTSS was also measured.
A trained evaluator demonstrated the test procedure while
giving standardized verbal instructions. Moreover, before testing,
participants were allowed to practice the sit-to-stand test twice.
Participants began by crossing their arms upon their chest and
sitting with their back against the chair (45 cm above the
floor). The chair was padded and armless. They were prompted
not to bounce off the chair when returning to the standing
position, and reminded to fully straighten their legs when
elevating. Participants were instructed to stand up and sit down
five times as quickly as possible. Performance was measured
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with a stopwatch in seconds, from the time at initial seated
position to the time at final seated position, after completing
five stands. A bedside face-to-face neuropsychological assessment
was also performed using the mini-mental state examination
(MMSE) (Folstein et al., 1975) and frontal assessment battery
(FAB) (Dubois et al., 2000), the French version of the free and
cued selective reminding test-total recall (FCSRT-TR) (Van der
Linden et al., 2004), parts A and B of the trail making test
(TMT) (Brown et al., 1958), the Stroop Test (Stroop, 1935),
and the instrumental activities of daily living scale (IADL)
(Pérès et al., 2006). The diagnosis was determined, following
a standardized procedure and consensual definition, during
multidisciplinary meetings involving geriatricians, neurologists,
and neuropsychologists of Angers University Memory Clinic.
It was based on the aforementioned neuropsychological tests,
physical examination findings, blood tests, and MRI or CT
scan of the brain. First, the cognitive status was determined
using the performances obtained during the neuropsychological
assessment. Participants were classified within cognitively healthy
individuals (CHI), a-MCI and na-MCI categories, diagnosis of
MCI being in accordance with the criteria detailed by Dubois
et al. (2010). CHI were individuals who exhibited normal
cognitive function with all cognitive scores using the referent
age-appropriate mean value. Participants with a-MCI and na-
MCI were individuals, who have an objective impairment in the
memory (i.e., a-MCI) or non-memory (i.e., na-MCI) domains,
respectively, defined as a score >1.5 SDs beneath the age-
appropriate mean, and who have not impaired daily living
activities (i.e., normal IADL score). Second, the etiology of MCI
(i.e., related to neurodegenerative brain lesions versus secondary
to metabolic disorders) was determined using the results of blood
tests and the brain MRI.
Definition of Motoric Cognitive Risk
Syndrome and Categorization of
Participants
Different definitions of MCR were used for each subgroup. First,
the diagnosis of MCR was made through slow walking speed
(MCRs) in accordance with the criteria described by Verghese
et al. (2013): a combination of cognitive complaint and slow
gait, with the absence of dementia or any mobility disability. As
cognitive complaint was the reason for referral to the memory
clinic for participants of the GAIT study, all of them met the
criteria for cognitive complaint. Slow gait speed was defined
as gait speed of one SD or greater, beneath the age-and sex-
appropriate mean values established by the present cohort, as
done in previous studies (Verghese et al., 2013, 2014). Second,
MCR was also defined using increased FTSS time (MCRf)
defined as time one SD or greater, above the age-and sex-
appropriate mean values established by the present cohort. Five
subgroups of individuals were identified: (1) those with MCRs
using gait speed exclusively; (2) those with MCRf using FTSS
time exclusively; (3) those with MCR with abnormal scores in
both gait speed and FTSS time (MCRsaf); (4) those with MCR
irrespective of mobility test used (MCRsof); and (5) those without
MCR.
Standard Protocol Approvals,
Registrations, and Patient Consent
This study was conducted in accordance with the ethical
standards set forth in the Helsinki Declaration (1983).
Participants in the study were included after obtaining written
informed consent for research. The local Angers Ethics
Committee approved the study protocol (n◦2009-A00533-54).
Statistics
The participants’ characteristics were summarized using means
and SDs or frequencies and percentages, as appropriate.
Between-group comparisons were performed using a Kruskal-
Wallis or Chi square test, Mann-Whitney, independent t-test;
unpaired t-test or Chi square test, as appropriate. Uni
and multiple logistic regression analyses were performed
to examine the relationship between MCR (i.e., dependent
variable) and MCI (i.e., independent variable), relative to
participants’ characteristics. P-values less than 0.05 were
considered statistically significant. All statistics were performed
using SPSS (version 23.0; SPSS, Inc., Chicago, IL, United States).
RESULTS
Table 1 illustrates the participants’ characteristics and their
comparisons between the different subgroups of participants
based on MCR definition. A total of 76 (12.0%) participants were
classified as having MCRs, 39 (6.2%) MCRf, 15 (2.4%) MCRsaf,
and 130 (20.5%) MCRsof. Individuals with MCR, irrespective of
the type of MCR, had the same clinical characteristics, except
for sex and level of education. Prevalence of women varied
between the different subgroups of MCR (P = 0.029), the highest
prevalence being observed with MCRs. Participants with MCRs
displayed a lower level of education when compared to those
with MCRf (P = 0.008). Participants with MCR displayed lower
limb proprioception when compared to non-MCR participants
(P = 0.042). The prevalence of MCI syndrome, regardless of type,
was significantly different between the three subgroups of MCR
(P = 0.039). The prevalence of a-MCI was lower in individuals
with MCRs when compared to those with MCRf (P = 0.010)
and MCRsaf (P = 0.018), whereas the prevalence of na-MCI was
higher in individuals with MCRs when compared to those with
MCRf (P = 0.010) and MCRsaf (P = 0.018). Those displaying
MCRf registered greater walking speeds when compared to those
with MCRs (P ≤ 0.001) and MCRsaf (P ≤ 0.001). Time to
perform FTSS was lower in individuals with MCRs (P ≤ 0.001)
and MCRsaf (P ≤ 0.001). Comparisons between individuals with
MCR, irrespective of definition, and without MCR show that
all characteristics differed significantly (P < 0.05), except for
age.
Multiple logistic regressions have shown a positive
relationship between MCRs and a-MCI and a more marked
(Table 2) negative relationship between MCRs and na-MCI
(P ≤ 0.020). All MCR, irrespective of definition, displayed a
positive relationship with MCI (all categories P = 0.010, a-MCI
P = 0.040 and na-MCI P = 0.046). These last relationships
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TABLE 2 | Logistic regressions showing the association between motoric cognitive risk syndrome and mild cognitive impairment (n = 633).
OR [95%CI] P-value∗
Walking speed† FTSS† Walking speed and FTTS Walking speed and/or FTTS
Model 1 Model 2 Model 1 Model 2 Model 1 Model 2 Model 1 Model 2
Mild cognitive impairment
All categories 1.60 0.99 1.40 1.29 2.34 1.87 – 1.95
[0.97;2.12] [0.57;1.71] [0.69;2.64] [0.63;2.64] [0.77;7.11] [0.59;5.94] [1.14;2.53] [0.78;1.89]
0.064 0.965 0.383 0.485 0.134 0.287 0.010 0.385
Amnestic 0.13 0.17 1.23 1.60 1.34 1.72 0.47 0.63
[0.03;0.57] [0.04;0.75] [0.45;3.32] [0.56;4.56] [0.34;5.40] [0.39;7.55] [0.23;0.97] [0.30;1.34]
0.007 0.019 0.686 0.578 0.677 0.475 0.040 0.232
Non-amnestic 2.70 2.40 0.90 0.78 0.86 0.76 1.44 1.25
[1.31;5.59] [1.15;5.04] [0.54;1.47] [0.46;1.32] [0.43;1.72] [0.36;1.60] [1.01;2.06] [0.86;1.82]
0.007 0.020 0.664 0.358 0.666 0.469 0.046 0.249
OR, odd ratio; CI, confidence interval; MCR, motoric cognitive risk syndrome; FTTS, five times sit-to-stand; ∗, separate model for gait speed; FTSS, gait speed and FTTS,
gait speed and/or FTTS; †, Exclusive (i.e., only participants with mean value of the motor test below 1 standard deviation); Model 1, adjusted for age and sex; Model 2,
adjusted for age, sex, number of drugs daily taken, body mass index, educational level, handgrip strength, distance vision acuity, and lower-limb proprioception. P-value
significant (i.e., P < 0.05) indicated in bold.
remained insignificant when logistic regressions were adjusted
for all participant characteristics.
DISCUSSION
The study findings demonstrate that the use of gait speed and
FTSS time to define MCR results in the selection of different
subgroups of individuals, with infrequent overlap (2.4%). In
contrast, there existed significant overlap between MCR and na-
MCI participants (up to 50%). In addition, only MCRs exhibited
a significant relationship with the MCI subgroups, the na-MCI
subtype, relating positively and the a-MCI relating negatively to
this MCR subgroup.
There existed infrequent overlap between individuals with
MCR as defined by gait speed and FTSS time. This result
suggests that impaired performance in these two motor tests
tracks different clinical phenotypes of individuals. But it is not
consistent with a previous study, which used alternate gait
parameters to define MCR and reported greater overlap (68%)
(Allali et al., 2016b). Comparatively, in the previous study the
definition used for the different subtypes of MCR involved low
performance of gait parameters (mean and variability of stride
length and swing time). In our study, even if both gait speed
and FTSS examine a condition of dynamic balance in which the
body’s center of gravity is maintained within a narrow base of
support while moving (Lord et al., 1991a; Dubost et al., 2005),
they relate to different brain regions, which may explain the
infrequent overlap observed (Lord et al., 1991a; Nutt et al., 1993;
Dubost et al., 2005; Rosano et al., 2007; Wittenberg et al., 2017).
For instance, gray matter volumes in the left frontal lobe were
correlated with usual gait speed in healthy older adults, whereas
reduced volumes in putamen and superior posterior parietal
lobule were associated with balancing difficulty in semi-tandem
stance (Rosano et al., 2007). Functional brain imagery study
findings point to involvement of the premotor, supplementary
motor, and parietal cortex in standing balance control, whereas
the hippocampus and premotor cortex are the key region for
gait control (Janssen et al., 2002; Rosano et al., 2007; Beauchet
et al., 2009, 2012, 2016; Spyropoulos et al., 2013; Wittenberg
et al., 2017). Subcortical regions have also been identified as
key regions for gait control including the cerebellar locomotor
region, the mesencephalic locomotor region, and the subthalamic
locomotor region (Bohnen et al., 2011). Gait speed is a surrogate
measure of gait, which is the medical term used to globally
describe the human locomotor movement of walking (Nutt et al.,
1993; Beauchet et al., 2017). Gait is a complex movement in
terms of biomechanics and motor control (Nutt et al., 1993;
Rosano et al., 2007; Beauchet et al., 2009, 2012; Wittenberg et al.,
2017). It has been highlighted that even the simplest walking
condition, such as straight-line walking at a comfortable steady-
state pace without any disturbances, involves cortical networks
and cognitive functions (Nutt et al., 1993; Rosano et al., 2007;
Beauchet et al., 2009; Wittenberg et al., 2017). This association
may explain the predictive value of slow gait for the occurrence
of dementia (Beauchet et al., 2016). In contrast, FTSS time
explores the performance of body transfer movement from a
seated position (Whitney et al., 2005). This movement is more
unstable in terms of biomechanics, when compared to walking
at a comfortable steady-state pace without any disturbances
(Spyropoulos et al., 2013). It involves an unstable movement from
a static and stable position to a quasi static position (Janssen
et al., 2002; Whitney et al., 2005; Bohnen et al., 2011; Schofield
et al., 2013; Spyropoulos et al., 2013; Lee et al., 2017). Thus,
FTSS time is strongly related to several physiological sensory
and motor subsystems which contribute to the dynamic postural
control, the most important ones identified in older adults being
the muscle strength, lower-limb proprioception, vestibular, and
vision subsystems (Janssen et al., 2002; Bohnen et al., 2011;
Schofield et al., 2013; Spyropoulos et al., 2013). Balance control
like gait control deteriorates with the progression of dementia
(Lee et al., 2017). This is similar to the decline of gait control
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with the progression of dementia (Annweiler et al., 2011).
Increased FTSS time has been associated with low cognitive
performance in older adults free of dementia (Annweiler et al.,
2011). This association has mainly been reported through bedside
cognitive tests exploring global cognitive functioning, such as the
MMSE the modified mini mental state (3MS) and Pfeiffer’s Short
Portable Mental State Questionnaire (Hirsch et al., 1997; Raji
et al., 2002; Rosano et al., 2005; Annweiler et al., 2011).
The second main finding of our study is the significant overlap
between MCI and MCR, irrespective of the criteria for MCR
definition. The prevalence of MCI was significantly higher in
individuals with MCR when compared to those without MCR,
and ranged from 52.6% for individuals with MCRs to 66.7%
for individuals with MCRsaf. In addition, the overlap between
MCR and MCI was greater for na-MCI when compared to
aMCI. This result concords with our previous study (Sekhon
et al., 2017) and underscores the strong relationship between
MCR and impaired cognitive performance, which explains the
ability for both syndromes to predict dementia (Verghese et al.,
2013, 2014; Beauchet et al., 2016; Sekhon et al., 2017). Cognition
and locomotion are two human abilities, which are controlled
by the brain (Nutt et al., 1993; Beauchet et al., 2009, 2012,
2016). Their decline is highly prevalent with physiological and
pathological aging, and is greater than the simple sum of their
respective prevalence, suggesting complex age-related interplay
between cognition and locomotion (Nutt et al., 1993; Rosano
et al., 2007; Beauchet et al., 2009, 2012, 2016; Wittenberg et al.,
2017). Recently, a systematic review and meta-analysis provided
evidence that poor gait performance could predict dementia
(Beauchet et al., 2016). We have previously reported that
individuals who exhibited both syndromes had poorer cognitive
performance in all domains when compared to participants
with MCI without MCR, and to participants with isolated MCR
(Sekhon et al., 2017).
Furthermore, the present study concludes that MCR related
positively to na-MCI and negatively to a-MCI. This result may
be related to studies that reported executive dysfunction in
individuals with MCR (Kumai et al., 2016; Belleville et al., 2017;
Sekhon et al., 2017). This correlation between MCRs and na-MCI
(but not with a-MCI) suggests that in our cohort (i.e., memory
clinic based), MCRs is associated with an underlying non-AD
process, such as vascular dementia or dementia with Lewy bodies,
but not with an underlying AD process. This double dissociation
is supported by the observation that at disease onset, gait speed
is more affected in non-AD dementia than in AD dementia
(Allali et al., 2016a). The absence of relationship between FTSS
time and MCI status suggests that there is no interaction with
cognitive performance in cognitively impaired individuals, such
as MCI individuals. This result was not expected because of the
previous positive relationship reported in CHI (Hirsch et al.,
1997; Raji et al., 2002; Rosano et al., 2005; Annweiler et al., 2011),
which underlines a non-linear complex relation between FTSS
time and decline in cognitive performance. This relationship
between MCRs and na-MCI supports that MCR appears to be a
good predictor of non-Alzheimer’s dementia, and in particular of
vascular dementia (Verghese et al., 2013, 2014). Furthermore, the
absence of any relationship with MCRf suggests that increased
FTSS tracks a profile for older adults which is not relevant in
identifying older adults who are at risk of dementia.
Our study has certain limitations. First, the cross-sectional
design does not allow us to make any causal association.
Secondly, the recruitment of participants was performed in one
center. Thirdly, all participants in this study presented a cognitive
complaint, preventing the generalization of study findings to
all non-demented community-dwelling older adults. Indeed, the
non-MCR/non-MCI participants cannot be considered as strictly
cognitively intact, but as participants with subjective cognitive
impairment (SCI). SCI is a prodromal state of MCI and is
considered the earliest clinical stage of dementia (Jessen et al.,
2014). Fourthly, we have no brain imaging data on the subset of
GAIT participants selected for this study.
CONCLUSION
The findings revealed that individuals with MCRf are distinct
from those with MCRs. MCRf status does not relate to MCI status
in the same way that MCRs does. A-MCI related negatively to
MCRs, whereas it related positively to na-MCI. All these results
suggest that using FTSS time in the definition of MCR is not
appropriate in order to identify older adults who are at risk of
dementia.
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